Geneva, Switzerland & Brussels, Belgium (PRWEB UK) 8 April 2013
Tech Tour and the International Venture Club announced today that the 2013 Healthtech Summit will be held on June 25-26, 2013. The first annual Healthtech Summit will be one of Tech Tours Vertical Summits to profile Europes 20 most dynamic companies to international investors with the theme, Crossing the chasm from start-up to a sustainable high growth business.”
Aris Constantinides, Founder and Investment Director of NBGI Ventures, will serve as Co-President of the Healthtech Summit and commented on the state of the industry in Europe and the particular choice of theme for this years event, The healthcare landscape is changing globally and on many levels: regulatory, economic, and technological. We chose the particular theme to this years summit as, amongst these strong winds of change, entrepreneurs are increasingly required to build their companies into real, sustainable and successful high growth businesses. Aside from highlighting Europes 20 most promising healthtech companies, this years Summit is aimed at helping entrepreneurs overcome these important challenges and thinking about building for the long-term.
Rudy Mareel, former CEO of Synthon and Co-President of the Healthtech Summit explained his vision and goals for the upcoming Summit saying, “Innovation is poised to play a greater role in the evolution of the healthcare market as demographic, regulatory and financial challenges play out. Yet, new product and services concepts often struggle to gain momentum in the larger institutions. Entrepreneurs, in contrast, have the freedom to develop ideas, but are faced with limited resources that can just as easily stifle their innovations. Thats why weve designed The Healthtech Summit as a space for young companies and resources to meet. We look forward to robust interaction between technology innovators, leaders of the various venture capital groups who invest in healthcare and key players from the industry.”
No charge to apply
No charge for selected companies to attend the event and present selection is merit only based
Companies are selected by an expert selection committee, according to their potential market impact
Selected companies will present to a group of 100+ global investment professionals, advisors and corporates.
Applicants can register for the Summit at http://www.healthtechsummit.eu
As part of the process applicants must submit a corporate presentation together with the registration form. The deadline for applications is May 15.
Applicants will be assessed on the uniqueness of their technology, the strength of their business model, vision, and capability to execute on the business plan and the quality and track record of their management. Submissions will be reviewed by the selection committee, which is comprised of senior business leaders from various backgrounds including venture capital, technology, research and economic promotion.
Rewards for Finalists
The selected 20 finalists will each have an opportunity to present their business plans to senior partners, vice presidents and CEOs from the global venture capital and technology industry, as well as service providers and academics. In addition, they will benefit from networking opportunities, local and international media exposure and potential opportunities to secure funding.
Previous Summit attendees included senior representatives of most major investment firms and corporates:
Addex, ARES Life Science, Auriga Partners, Baxter International, Bay City Capital, BioBay, Biosensors, Boston Scientific, CDC Innovation, Creathor Venture, Credit Agricole Private Equity, Credit Suisse, Cukierman & Co. Life Sciences, Decheng Capital, Delta Partners, DFJ Esprit, Earlybird Venture Capital, Edwards Life Science, EIF, Endeavour Vision, Eurofin Ventures, Entrepreneurs Fund Management, EPFL, EuroUS Ventures, Fountain, Healthcare Partners, Gilde Healthcare Partners, GIMV, Go4Ventures, Index Ventures, Inventure Capital, Johnson & Johnson, Kreos Capital, Linde Healthcare, Medtronic, MVM Life Science Partners, NASA, NeoMed, Novartis Ventures, Polytech Ventures, Rothschild Group, Scottish Equity Partners, Siemens, Sofimac Partners Investment Capital, Sofinnova, Sony, Stryker, Trigon Medical, Valtronic Technologies, Wellington Partners.
Companies that have presented in previous Summits have either been acquired or raised more than $ 1 Billion in funding. Some notable examples can be found at http://www.iventureclub.com/events/view.aspx?events_pages_id=1764.
About the Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour is an independent, not-for-profit organization composed of key contributors to the high technology industry. The organization recognizes that continued prosperity in Europe lies in its ability to transform today’s innovative projects into tomorrow’s global technology leaders.
About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies.